Clinical trial
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in…
NCT00021801 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00021801 |
|---|---|
| Title | Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen |
| Official title | Pathways to Tolerance in Human Islet Transplantation |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Procedure |
| Interventions | Islet Cell Transplantation |
| Start date | Mar 1, 2000 |
| Completion | Sep 1, 2000 |
| First posted | Aug 6, 2001 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: